Toggle navigation
Request a Rep Visit
|
Keep in touch with Sanofi
For Healthcare Professionals only
A
A
A
Toggle navigation
Venous Thromboembolism
Toggle Dropdown
Epidemiology
Haemostasis
Risk Factors and Risk Assessment
Thromboprophylaxis
Treatment
Literature
References
Clexane (enoxaparin)
Toggle Dropdown
Substance Profile
Production Process
Mechanism of Action
Monitoring
Use in patients with renal impairment
Overdose
SPC
Patient Materials
Toggle Dropdown
Patient Materials Arabic
Patient Materials Bengali
Patient Materials English
Patient Materials Greek
Patient Materials Gujurati
Patient Materials Hindi
Patient Materials Lithuanian
Patient Materials Polish
Patient Materials Portuguese
Patient Materials Punjabi
Patient Materials Romanian
Patient Materials Russian
Patient Materials Simplified Chinese
Patient Materials Somali
Patient Materials Traditional Chinese
Patient Materials Urdu
Patient Materials Spanish
Patient Materials Welsh
Adverse Event Reporting
Prescribing Information
Toggle Dropdown
Prescribe by brand
Prescribing Information
Supply Information
You need to enable JavaScript in Your browser
Supply information
More
Thromboprophylaxis
More
Risk Factors & Risk Assessment
More
CLEXANE RESOURCES
More
Mechanism of action
More
Clexane [enoxaparin]
More
Venous Thromboembolism
More
Haemostasis
More
Venous Thromboembolism
More
Clexane [enoxaparin]
More
Supply information
More
Haemostasis
More
Risk Factors & Risk Assessment
More
Thromboprophylaxis
More
Resources
More
Literature
More
Home
VTE Matters
To the top
